cannbis hyperemesis syndrome similar episodes seen but now liitke severe h/0 cannabis usein last 24 hrs tretment plan in usa
Reading File
Finding Sources
Searching PubMed
"cannabinoid hyperemesis syndrome" diagnosis treatment
Searching the Web
cannabinoid hyperemesis syndrome no recent cannabis use differential diagnosis treatment 2025
Reading File
Reading File
Reading File
Reading File
Reading Article
I now have enough to provide a thorough, well-structured clinical answer. Here it is:
CHS-Like Episode With No Cannabis Use in Last 24 Hours - Clinical Assessment & Treatment Plan
The Core Clinical Problem
This presentation - CHS-pattern cyclic vomiting with known prior CHS episodes, but no cannabis use in the last 24 hours - is a genuinely complex diagnostic challenge. It requires you to:
- Consider cannabis withdrawal as a trigger (not the same as active use)
- Broaden the differential to rule out serious mimics
- Treat the acute episode symptomatically while working up the cause
Why "No Use in Last 24 Hours" Changes Everything
CHS classically resolves with cannabis cessation. However, an acute episode in the setting of recent abstinence can represent:
- Cannabis withdrawal hyperemesis - THC has a long half-life (days to weeks in heavy users); withdrawal can trigger or perpetuate nausea/vomiting. This is a recognized phenomenon and may still respond to capsaicin/haloperidol.
- True CHS relapse with underreported or resumed use - patients frequently underreport
- Cyclic Vomiting Syndrome (CVS) - phenotypically identical to CHS; cannabis use may have been masking/treating CVS all along. CVS is episodic by nature.
- Unrelated acute pathology - the 24-hour window is significant; a new etiology must be excluded.
"The manifestations of cannabinoid hyperemesis syndrome are indistinguishable from those of CVS, with similar onset, duration, and frequency of episodes." - Sleisenger & Fordtran's Gastrointestinal and Liver Disease
Step 1: Rule Out Life-Threatening Mimics First
Mandatory workup before diagnosing CHS/CVS:
| Rule Out | Tests |
|---|---|
| Bowel obstruction / perforation | Abdominal X-ray or CT abdomen/pelvis |
| Pancreatitis | Lipase, amylase |
| Cholecystitis / cholangitis | RUQ ultrasound, LFTs, bilirubin |
| Appendicitis | CT abdomen (if indicated) |
| Gastroparesis | History, consider gastric emptying scan later |
| DKA | BMP, glucose, urinalysis |
| Adrenal insufficiency | If recurrent, consider AM cortisol |
| Ectopic pregnancy (if female, reproductive age) | urine hCG |
| Nephrolithiasis | UA, CT |
| Intracranial pathology | Neuro exam; consider head CT if headache/focal signs |
| Pheochromocytoma | If hypertensive during episodes |
Urine toxicology: Order urine drug screen. A negative THC in a heavy chronic user after <24 hours of abstinence would be unusual (THC is detectable for days to weeks). A positive urine THC still does not confirm active use in last 24 hours - it only confirms recent use.
Step 2: Acute ED / Inpatient Treatment Plan (USA)
A. Supportive Care (Always First)
- IV access + fluid resuscitation - normal saline for dehydration and electrolyte replacement
- BMP - check sodium, potassium, bicarbonate (metabolic alkalosis common from vomiting)
- NPO initially, then advance diet as tolerated
B. Antiemetics - Preferred in CHS / Cannabis-Related Emesis
| Medication | Dose | Notes |
|---|---|---|
| Haloperidol | 0.05 mg/kg IV or 5 mg IV/IM (adults) | First-line for CHS in ED; dopamine D2 antagonist. Check QTc first - hold if QTc prolonged (males >460 ms, females >480 ms) |
| Lorazepam | 1-2 mg IV q4-6h | Adjunct; reduces anxiety/retching reflex |
| Droperidol | 1.25-2.5 mg IV/IM | Alternative to haloperidol; similar mechanism |
| Ondansetron | 4-8 mg IV | Often used but less effective in CHS than typical antiemetics |
| Metoclopramide | 10 mg IV | Second-line |
| Promethazine | 12.5-25 mg IV/IM | QTc caution; avoid in children |
"ED treatment of CHS includes the use of capsaicin cream as well as haloperidol or lorazepam." - Rosen's Emergency Medicine"The most effective treatment [in the ED] is cessation of marijuana use." - Rosen's Emergency Medicine (but this applies when cannabis is actively being used)
C. Capsaicin Cream (Topical)
- Apply to abdomen - 0.025% to 0.075% cream; can repeat q6h
- Mechanism: depletes substance P at TRPV1 receptors in skin; appears to interrupt the same pathway that hot water stimulates
- This is a particularly useful, low-risk adjunct
- Availability: OTC (Zostrix, generic), prescription-strength not required
- Note: the hot shower/bath behavior in CHS works by the same TRPV1 mechanism
D. Rehydration + Electrolytes
- Correct hypokalemia (common from vomiting)
- Correct metabolic alkalosis if severe
- Magnesium sulfate IV if hypomagnesemic (common in chronic cannabis users)
Step 3: Is This CVS Now?
If urine THC returns negative (unlikely in <24h from chronic use but possible), or if the patient has been abstinent for several days prior and this is a breakthrough episode, strongly consider CVS as the primary diagnosis:
CVS Rome IV Criteria:
- Stereotypical episodes of vomiting with acute onset lasting <1 week
- At least 3 discrete episodes in prior year, 2 in prior 6 months
- No vomiting between episodes (or far less)
- Not explained by another disorder
CVS-specific abortive treatment (US):
- Triptans (sumatriptan 6 mg SC, 20 mg intranasal, or 25-100 mg oral at episode onset) - first-line abortive for CVS
- Aprepitant (NK1 antagonist) - increasingly used
- Ondansetron for symptom control
- Lorazepam for sedation/antiemetic effect
- Amitriptyline (10-75 mg/night) or topiramate - for prophylaxis if episodes are frequent
Step 4: Outpatient Follow-Up Plan
- Addiction medicine / cannabis cessation referral if active user - this is the only definitive treatment for CHS
- Gastroenterology referral - for formal CHS vs CVS workup, gastric emptying study if indicated
- Motivational interviewing - non-confrontational discussion about cannabis abstinence
- If CVS suspected: neurology consult or GI motility specialist
- Urine THC monitoring at follow-up visits
Key Clinical Decision Points Summary
| Finding | Action |
|---|---|
| QTc prolonged | Avoid haloperidol/droperidol; use lorazepam + capsaicin |
| Urine THC negative (verified abstinence) | Pivot to CVS workup; start triptans |
| Positive imaging (obstruction, pancreatitis, etc.) | Treat underlying cause; do not diagnose CHS |
| Fails typical CHS treatment | Broaden differential; admit for monitoring |
| Female + reproductive age | Check hCG first |
Sources
- Rosen's Emergency Medicine: Concepts and Clinical Practice - Ch. 25 (CHS key concepts, haloperidol + capsaicin ED treatment)
- Sleisenger & Fordtran's Gastrointestinal and Liver Disease - CHS vs CVS overlap, abstinence requirement
- Yamada's Textbook of Gastroenterology, 7th Ed. - CHS phases, hot bathing behavior, cessation leads to resolution
- Rubio-Tapia A et al. "AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome." Gastroenterology 2024 [PMID: 38456869]
- Children's Minnesota CHS Clinical Pathway (2025) - QTc thresholds, diagnostic criteria
Bottom line: Treat the acute episode with IV fluids, haloperidol (after QTc check), and topical capsaicin. Simultaneously rule out serious mimics with targeted labs and imaging. With no confirmed active cannabis use, pivot toward CVS evaluation and consider triptans. Long-term: cannabis cessation is the only definitive intervention for CHS.
h/0 of cannabis in last 24 hr si said
You're right - re-reading your original message: "h/o cannabis use in last 24 hrs" means the patient HAS used cannabis in the last 24 hours. That is classic active CHS. My apologies for the misread.
Let me give you the corrected, focused treatment plan:
CHS - Active Cannabis Use in Last 24 Hours - ED Treatment Plan (USA)
Diagnosis is Confirmed / High Probability
With:
- Prior similar episodes (established pattern)
- Active cannabis use within 24 hours
- Cyclic vomiting + abdominal pain
- Likely compulsive hot bathing behavior
This is CHS until proven otherwise. Still rule out dangerous mimics quickly.
Rapid Workup (Do Not Delay Treatment)
| Test | Purpose |
|---|---|
| BMP | Electrolytes, glucose, renal function |
| Lipase | Rule out pancreatitis |
| Urine hCG (females) | Rule out ectopic pregnancy |
| Urine drug screen | Confirm THC; rule out coingestants |
| UA | Rule out UTI, nephrolithiasis |
| Abdominal X-ray | Only if obstruction suspected |
| LFTs | If jaundice or RUQ pain present |
CT abdomen is NOT routine - reserve for atypical features or diagnostic uncertainty.
ED Treatment Protocol
1. IV Access + Fluid Resuscitation
- Normal saline 1-2L bolus for dehydration
- Correct hypokalemia, hypomagnesemia (common with prolonged vomiting)
- NPO initially
2. Check QTc Before Antidopaminergics
- Males: hold if QTc >460 ms
- Females: hold if QTc >480 ms
3. Antiemetic Ladder (CHS-Specific)
| Drug | Dose | Priority |
|---|---|---|
| Haloperidol | 5 mg IV/IM (adults); 0.05 mg/kg peds | First-line - most evidence in CHS |
| Droperidol | 1.25-2.5 mg IV/IM | Alternative first-line |
| Lorazepam | 1-2 mg IV q4-6h | Adjunct; reduces retching, anxiety |
| Metoclopramide | 10 mg IV q6h | Second-line if above unavailable |
| Ondansetron | 4-8 mg IV | Less effective in CHS than in other vomiting; use as add-on only |
Why haloperidol over ondansetron? CHS involves dysregulated dopaminergic/endocannabinoid pathways. D2 blockers (haloperidol, droperidol) are mechanistically superior to 5-HT3 blockers in this condition.
4. Capsaicin Cream - Do Not Forget This
- Apply 0.025%-0.075% cream to abdomen
- Reapply every 6 hours
- Works via TRPV1 receptor activation - same mechanism as the compulsive hot shower behavior
- OTC available (Zostrix or generic); no prescription needed
- Very low risk, clinically meaningful benefit in CHS
5. Diphenhydramine (Benadryl)
- 25-50 mg IV - use as adjunct to prevent haloperidol-induced akathisia
- Also mild antiemetic effect
Disposition
| Scenario | Disposition |
|---|---|
| Responds to ED treatment, tolerates PO, vitals stable | Discharge with close follow-up |
| Persistent vomiting, significant dehydration, electrolyte abnormalities | Admit |
| Diagnostic uncertainty (labs/imaging abnormal) | Admit for further workup |
Discharge Plan
- Cannabis cessation counseling - this is the ONLY definitive cure for CHS
- Symptoms fully resolve within 1-3 months of complete abstinence in most patients
- Relapse = return of symptoms
- Avoid hot showers as a coping strategy - it reinforces cannabis use behavior and delays cessation
- Outpatient follow-up with PCP or GI within 1-2 weeks
- Motivational interviewing / addiction medicine referral if available
- Return precautions: inability to keep fluids down, signs of severe dehydration, new/different symptoms
What NOT to Do in CHS
- Do not give opioids - they worsen GI dysmotility and are frequently sought by CHS patients inadvertently
- Do not give ondansetron as monotherapy - inadequate for CHS mechanism
- Do not diagnose CHS without ruling out pancreatitis, obstruction, ectopic pregnancy
- Do not miss the hot shower history - ask specifically; patients often don't volunteer it
Bottom line: Haloperidol + capsaicin cream + IV fluids is the core CHS regimen. Definitive treatment is cannabis cessation. Discharge with cessation counseling and close follow-up unless they fail to respond or have red flag features.
is draminene 50 mg okay
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.